# Different Safety Profile of Risperidone and Paliperidone Extended-release

> **NCT01284959** · PHASE4 · COMPLETED · sponsor: **Chonbuk National University Hospital** · enrollment: 34 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** risperidone
- **DRUG:** paliperidone ER
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01284959
- **Lead sponsor:** Chonbuk National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2010-07
- **Final completion:** 2010-12
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2012-10-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01284959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01284959, "Different Safety Profile of Risperidone and Paliperidone Extended-release". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01284959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*